Neuromuscular disease

Muscular dystrophy—something new on God's green earth?

Promising results on newborn testing for Duchenne muscular dystrophy indicate that widespread screening could become routinely available. Nevertheless, newborn testing raises ethical, social and scientific concerns that need careful consideration to maximize benefit for patients, their families and health-care providers.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Mendell, J. R. et al. Evidence based path to newborn screening for Duchenne muscular dystrophy. Ann. Neurol. http://dx.doi.org/10.1002/ana.23528.

  2. 2

    Bowman, J. E. Screening newborn infants for Duchenne Muscular dystrophy. BMJ 306, 349 (1993).

    CAS  Article  Google Scholar 

  3. 3

    Parsons, E. P., Bradley, D. M. & Clarke, A. J. Newborn screening for Duchenne muscular dystrophy. Arch. Dis. Child. 88, 91–92 (2003).

    CAS  Article  Google Scholar 

  4. 4

    Elliman, D. A., Dezateux, C. & Bedford, H. E. Newborn and childhood screening programmes: criteria, evidence, and current policy. Arch. Dis. Child. 87, 6–9 (2002).

    CAS  Article  Google Scholar 

  5. 5

    Kemper, A. R. & Wake, M. A. Duchenne muscular dystrophy: issues in expanding newborn screening. Curr. Opin. Pediatr. 19, 700–704 (2007).

    Article  Google Scholar 

  6. 6

    Moxley, R. T. 3rd, Pandya, S., Ciafaloni, E., Fox, D. J. & Campbell, K. Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management. J. Child. Neurol. 25, 1116–1129 (2010).

    Article  Google Scholar 

  7. 7

    Hennekam, R. C. Care for patients with ultra-rare disorders. Eur. J. Med. Genet. 54, 220–224 (2011).

    Article  Google Scholar 

  8. 8

    Campbell, E. & Ross, L. F. Parental attitudes regarding newborn screening of PKU and DMD. Am. J. Med. Genet. A. 120A, 209–214 (2003).

    Article  Google Scholar 

  9. 9

    Pollitt, R. J. New technologies extend the scope of newborn blood-spot screening, but old problems remain unresolved. Acta Paediatr. 99, 1766–1772 (2010).

    Article  Google Scholar 

  10. 10

    Elliman, D. Ethical aspects of the expansion of neonatal screening programme due to technological advances. Clin. Chem. Lab. Med. http://dx.doi.org/10.1515/cclm.2011.761s

Download references

Acknowledgements

A. Ferlini is supported by the Telethon Italy Foundation, the BIO-NMD project, the TREAT-NMD Network of Excellence and the Duchenne Parent Project Italy.

Author information

Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ferlini, A. Muscular dystrophy—something new on God's green earth?. Nat Rev Neurol 8, 247–249 (2012). https://doi.org/10.1038/nrneurol.2012.41

Download citation

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing